Industrial Biotechnology (IB) has been identified as one of the key enabling technologies which can drive European competitiveness in the coming decades and help develop a more sustainable and resource-efficient Europe. However, major hurdles hamper the full exploitation of IB. These include access to feedstock and financing, low public awareness of the benefits of IB products, a lack of incentives and various technological constraints.
The European Commission highlighted the importance of research and innovation (R&I) investments and reforms for economic recovery in the European Union, and made proposals to help EU Member States maximise the impact of their budgets at a time when many countries still face spending constraints.
LightJumps European project coordinated by PNO, is conducting a survey to identify barriers and needs of European companies/organizations operating in the Photonics sector. Give us your help to strengthen the Photonics sector in Europe!
BIO-TIC is proud to announce the public launch of three “bio-Roadmaps” focusing on the market potential, R&D priorities and non-technological hurdles of IB innovation in Europe.
The EU Industrial Structure Report 2013 analyses the performance of EU industrial and service sectors in terms of productivity and its underlying drivers, the resultant changes to industrial and export specialization, comparative advantages at EU and national level, and the position of the EU in increasingly global value chains. This edition also looks at the impact of the crisis and the difficult recovery on long-term structural trends.